Recent Advances in Covalent and Non-Covalent Drug Discovery with TMT Quantitative Chemoproteomics

Explore cutting-edge developments in drug discovery through this comprehensive webinar featuring presentations by Dr. Alexey Chernobrovkin and Dr. Qing Yu. Discover how TMT (Tandem Mass Tag) quantitative chemoproteomics is revolutionizing both covalent and non-covalent drug discovery approaches by bridging theoretical insights with practical applications. Learn about recent technological advancements that expand TMT quantitation utility from an academic perspective, while gaining insights into real-world applications, challenges, and solutions for characterizing protein targets and mechanisms of action from an industry expert. Understand how TMT multiplexing enhances proteome analysis accuracy and depth in drug discovery contexts, driving forward both scientific research and industrial applications. Gain comprehensive knowledge of leveraging TMT reagents to advance proteomics research and overcome practical challenges in characterizing drug-protein interactions across different binding modalities.